51079-670 NDC - METHOTREXATE ()

Drug Information

Product NDC: 51079-670

Proprietary Name: Methotrexate

Non Proprietary Name:

Active Ingredient(s):


Administration Route(s):

Dosage Form(s):

Labeler Information

Labeler Name: Mylan Institutional Inc.
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:7/12/1995
End Marketing Date:1/31/2030

Package Information

No. Package Code Package Description Billing Unit
151079-670-0520 BLISTER PACK in 1 CARTON (51079-670-05) / 1 TABLET in 1 BLISTER PACK (51079-670-01)EA

NDC Record

Field Name Field Value Definition
PRODUCT NDC51079-670The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEMethotrexateThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE7/12/1995This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE1/31/2030This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
LABELER NAMEMylan Institutional Inc.Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023